Serotonin-induced muscle weakness.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D003533:Cyproheptadine / Q000494:pharmacology; D003864:Depression, Chemical; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009132:Muscles / Q000187:drug effects* / Q000201:enzymology; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000494:pharmacology*; D012702:Serotonin Antagonists; D013778:Tetrazolium Salts; D013997:Time Factors
D012702:Serotonin Antagonists; D013778:Tetrazolium Salts; D003533:Cyproheptadine; D012701:Serotonin; D007770:L-Lactate Dehydrogenase; D009247:NADH, NADPH Oxidoreductases; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase; D000251:Adenosine Triphosphatases; D005634:Fructose-Bisphosphate Aldolase; D008784:Methysergide